Clinical Trials

Showing trials with last updates posted in 2026.

NCT06167486 | COMPLETED | PHASE1
17 participants

SG2918 For Advanced Malignant Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2023-12-26
Completion:
2025-11-11
Conditions
  • Advanced Malignant Tumors
Interventions
  • DRUG
No Results Yet
NCT06126276 | RECRUITING | PHASE2
70 participants

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2024-05-07
Completion:
2027-02-20
Conditions
  • Malignant Female Reproductive System Neoplasm
  • Malignant Solid Neoplasm
  • Recurrent Malignant Female Reproductive System Neoplasm
  • Recurrent Malignant Solid Neoplasm
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT06124157 | RECRUITING | PHASE2
222 participants

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2025-05-30
Completion:
2030-12-01
Conditions
  • B Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
  • RADIATION
No Results Yet
NCT06112860 | RECRUITING | NA
50 participants

OTC Hearing Aid and MCI

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2024-07-23
Completion:
2026-12-31
Conditions
  • Hearing Loss
  • Mild Cognitive Impairment
  • Alzheimer Disease and Related Dementias (ADRD)
Interventions
  • DEVICE
  • BEHAVIORAL
No Results Yet
NCT06072924 | RECRUITING | NA
70 participants

K01 Impacts of Lingual Endurance Exercise

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2023-09-01
Completion:
2027-08-31
Conditions
  • Dysphagia
  • Dysphagia, Oropharyngeal
  • Ischemic Stroke
  • Stroke
Interventions
  • BEHAVIORAL
No Results Yet
NCT06058377 | RECRUITING | PHASE3
3680 participants

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2023-11-27
Completion:
2032-05-31
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Hormone Receptor-Positive Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT06053697 | ACTIVE_NOT_RECRUITING
120 participants

Is the Vaginal Microbiome and Metabolome Associated With Spontaneous Preterm Birth (sPTB) in Multiple Pregnancies?

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-04
Start Date:
2022-07-05
Completion:
2027-04-30
Conditions
  • Preterm Birth
  • Preterm Labor
  • Multiple; Pregnancy, Complicated
  • Twin Dichorionic Diamniotic Placenta
  • Twin Monochorionic Monoamniotic Placenta
  • Twin; Pregnancy, Affecting Fetus or Newborn
  • Vaginal Microbiome
  • Cervical Stiffness
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page